BELLUS Health Inc. Gains 28.87%
Wed 18 Nov 20 at 05:30 PM
BELLUS Health Inc. (BLU:NASDAQ) rocketted at $3.08, representing a gain of 28.9%. The stock got featured on our News Catalysts scanner on Thu 12 Nov 20 at 08:57 AM in the 'EARNINGS' category. From Tue 03 Nov 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About BELLUS Health Inc. (BLU:NASDAQ)
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.
Top 10 Gainers:
- NMMC (NMMC:NASDAQ), 1900%
- Phoenix Tree Holdings Limited (DNK:NYSE), 90.42%
- Naked Brand Group Limited (NAKD:NASDAQ), 47.16%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 36.34%
- VAALCO Energy, Inc. (EGY:NYSE), 32.35%
- Micro Focus International plc (MFGP:NYSE), 30%
- China HGS Real Estate Inc. (HGSH:NASDAQ), 29.71%
- BELLUS Health Inc. (BLU:NASDAQ), 28.87%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 27.16%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 23.79%